Technology and early-stage support contributing to IQTech’s initial foundation.
Progress is never
built alone.
IQTech develops through a network of scientific institutions, technology partners and strategic investors who contribute knowledge, validation, capital and access to new opportunities.
From clinical knowledge
to validated innovation.
IQTech works with medical universities and academic partners around healthcare education, clinical knowledge and the scientific validation of technology-enabled training experiences.
These collaborations are especially important for Esculapio, where innovation must remain connected to credible clinical logic, educational methodology and real institutional needs.
From early backing
to global scale.
IQTech has already secured more than $200K in funding. The current $500K round represents the next step toward a broader long-term capital strategy for international growth.
Strategic capital supporting product development and long-term company growth.
Funding closed before the current investment round.
Current investment round now opening.
Long-term capital ambition supporting IQTech’s international scale and growth strategy.
The next chapter
is open.
After securing more than $200K in previous funding, IQTech is opening a $500K investment round to accelerate product development, scientific expansion and international growth.
Discuss the investment round ↗Different ways to build together.
Universities, medical schools, hospitals, simulation centers and research organizations.
↗ 02Organizations bringing complementary capabilities, distribution or specialized expertise.
↗ 03Investors interested in AI, XR, healthcare technology and international innovation.
↗